利润表（开立医疗）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 1,398,196,592.81 | 1,012,691,317.35 | 479,333,865.45 | 2,120,251,604.73 | 1,467,832,830.33 | 1,043,339,390.90 | 473,030,518.35 |
| 营业收入(元) | 1,398,196,592.81 | 1,012,691,317.35 | 479,333,865.45 | 2,120,251,604.73 | 1,467,832,830.33 | 1,043,339,390.90 | 473,030,518.35 |
| 二、营业总成本(元) | 1,351,044,835.32 | 872,746,020.51 | 394,005,611.99 | 1,665,265,681.56 | 1,145,708,757.88 | 761,809,244.07 | 358,549,235.76 |
| 营业成本(元) | 467,203,720.24 | 329,854,804.92 | 146,687,089.41 | 648,554,377.98 | 459,094,202.17 | 323,627,832.20 | 148,528,324.04 |
| 研发费用(元) | 338,307,834.78 | 212,179,984.55 | 101,637,595.01 | 384,256,460.57 | 263,619,138.72 | 169,796,135.10 | 80,009,904.74 |
| 营业税金及附加(元) | 13,164,362.01 | 9,605,480.72 | 4,343,980.51 | 24,436,134.44 | 18,203,227.43 | 13,480,320.77 | 6,480,792.32 |
| 销售费用(元) | 458,783,435.33 | 287,288,362.53 | 122,907,237.61 | 524,364,856.42 | 352,750,664.36 | 231,504,764.80 | 105,681,831.55 |
| 管理费用(元) | 100,941,379.20 | 62,817,254.23 | 34,545,545.65 | 128,328,978.83 | 84,901,395.32 | 55,375,184.05 | 25,153,021.09 |
| 财务费用(元) | -27,355,896.24 | -28,999,866.44 | -16,115,836.20 | -44,675,126.68 | -32,859,870.12 | -31,974,992.85 | -7,304,637.98 |
| 其中：利息费用(元) | 4,636,853.16 | 2,405,886.71 | 841,323.50 | 5,053,850.45 | 4,384,236.65 | 3,374,625.55 | 1,538,530.23 |
| 其中：利息收入(元) | 36,827,182.90 | 28,191,946.34 | 17,014,603.44 | 46,665,187.01 | 21,478,174.57 | 23,777,683.16 | 15,194,145.19 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | 3,907,207.41 | 2,465,494.69 | 113,973.75 | -175,542.46 | -10,823,354.91 | -16,605,338.68 | 3,312,105.93 |
| 加：投资收益(元) | -2,487,958.79 | -2,939,022.18 | -1,950,941.60 | -12,667,407.84 | -5,031,538.78 | 2,878,894.73 | 2,134,750.03 |
| 资产处置收益(元) | 11,857.35 | - | - | 20,353.98 | 20,353.98 | -3,963.53 | 20,353.98 |
| 资产减值损失(元) | -10,117,222.04 | -10,117,222.04 | - | -51,118,951.10 | -9,040,202.13 | -9,040,202.13 | - |
| 信用减值损失(元) | -8,437,016.82 | -15,350,738.79 | -7,656,364.29 | -14,336,403.56 | -22,113,007.91 | -20,433,918.58 | -7,297,543.87 |
| 其他收益(元) | 85,674,244.83 | 62,805,425.56 | 35,198,992.96 | 98,106,549.83 | 74,598,997.58 | 52,791,894.04 | 36,777,088.58 |
| 四、营业利润(元) | 115,702,869.43 | 176,809,234.08 | 111,033,914.28 | 474,814,522.02 | 349,735,320.28 | 291,117,512.68 | 149,428,037.24 |
| 加：营业外收入(元) | 766,289.65 | 636,881.84 | 600,311.26 | 218,623.73 | 196,542.58 | 50,556.92 | 31,879.36 |
| 减：营业外支出(元) | 877,200.30 | 814,360.24 | 97,158.16 | 1,202,132.63 | 995,420.78 | 292,102.56 | 283,417.57 |
| 五、利润总额(元) | 115,591,958.78 | 176,631,755.68 | 111,537,067.38 | 473,831,013.12 | 348,936,442.08 | 290,875,967.04 | 149,176,499.03 |
| 减：所得税费用(元) | 6,606,159.31 | 6,058,405.32 | 11,346,239.75 | 19,393,538.51 | 28,319,294.00 | 17,816,121.26 | 10,702,112.74 |
| 六、净利润(元) | 108,985,799.47 | 170,573,350.36 | 100,190,827.63 | 454,437,474.61 | 320,617,148.08 | 273,059,845.78 | 138,474,386.29 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 108,985,799.47 | 170,573,350.36 | 100,190,827.63 | 454,437,474.61 | 320,617,148.08 | 273,059,845.78 | 138,474,386.29 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 108,985,799.47 | 170,573,350.36 | 100,190,827.63 | 454,437,474.61 | 320,617,148.08 | 273,059,845.78 | 138,474,386.29 |
| 扣除非经常性损益后的净利润(元) | 86,116,151.45 | 154,937,603.05 | 92,202,886.77 | 442,470,555.58 | 321,441,624.15 | 273,092,726.63 | 125,533,224.91 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 0.25 | 0.40 | 0.23 | 1.06 | 0.75 | 0.64 | 0.32 |
| 二、稀释每股收益(元) | 0.25 | 0.39 | 0.23 | 1.05 | 0.74 | 0.63 | 0.32 |
| 八、其他综合收益(元) | 2,331,694.88 | -291,499.80 | 1,662,272.04 | 5,208,154.07 | 7,212,683.34 | 2,010,714.80 | -623,608.77 |
| 归属于母公司股东的其他综合收益(元) | 2,331,694.88 | -291,499.80 | 1,662,272.04 | 5,208,154.07 | 7,212,683.34 | 2,010,714.80 | -623,608.77 |
| 九、综合收益总额(元) | 111,317,494.35 | 170,281,850.56 | 101,853,099.67 | 459,645,628.68 | 327,829,831.42 | 275,070,560.58 | 137,850,777.52 |
| 归属于母公司所有者的综合收益总额(元) | 111,317,494.35 | 170,281,850.56 | 101,853,099.67 | 459,645,628.68 | 327,829,831.42 | 275,070,560.58 | 137,850,777.52 |
| 公告日期 | 2024-10-26 | 2024-08-29 | 2024-04-27 | 2024-04-12 | 2023-10-26 | 2023-08-23 | 2023-04-27 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 41 of 41 entries